Mitoxantrone hydrochloride liposome-based chemotherapy plus rituximab in elderly patients older than 80 years with diffuse large B-cell lymphoma: case report and review of the literature
These cases suggest that mitoxantrone hydrochloride liposome-based chemotherapy may be effective (all three cases achieved CMR) in very elderly DLBCL patients, warranting further evaluation in larger cohorts.
Authors
- Wei Zhang (ORCID: https://orcid.org/0000-0001-6937-5562)
- Ying Liu (ORCID: https://orcid.org/0000-0003-1699-9309)
- Jinping Pi (ORCID: https://orcid.org/0009-0002-7907-9809)
- Xiao‐Hui He
- Jun Jin (ORCID: https://orcid.org/0000-0001-7675-5950)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fmed.2025.1629168
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00